| Primary |
| Atrial Fibrillation |
30.9% |
| Drug Use For Unknown Indication |
19.8% |
| Product Used For Unknown Indication |
16.8% |
| Arrhythmia |
7.2% |
| Hypertension |
5.9% |
| Thrombosis Prophylaxis |
4.3% |
| Depression |
2.9% |
| Pain |
2.0% |
| Anticoagulant Therapy |
1.4% |
| Extrasystoles |
1.2% |
| Pulmonary Embolism |
1.2% |
| Diabetes Mellitus |
1.0% |
| Wolff-parkinson-white Syndrome |
1.0% |
| Lymphoma |
0.8% |
| Mitral Valve Replacement |
0.8% |
| Anaemia Of Malignant Disease |
0.6% |
| Atrial Flutter |
0.6% |
| Cardiac Disorder |
0.6% |
| Cardiac Failure Congestive |
0.6% |
| Cardiac Fibrillation |
0.6% |
|
| Drug Ineffective |
13.5% |
| Atrial Fibrillation |
8.7% |
| Ventricular Tachycardia |
7.7% |
| Syncope |
5.8% |
| Heart Rate Irregular |
4.8% |
| Somnolence |
4.8% |
| Tachycardia |
4.8% |
| Treatment Noncompliance |
4.8% |
| Chest Pain |
3.8% |
| Drug Effect Decreased |
3.8% |
| Drug Screen False Positive |
3.8% |
| Dyspnoea |
3.8% |
| Sick Sinus Syndrome |
3.8% |
| Sinus Bradycardia |
3.8% |
| Sinus Headache |
3.8% |
| Tremor |
3.8% |
| Ventricular Flutter |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Wound Infection Bacterial |
3.8% |
| Adverse Event |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.1% |
| Atrial Fibrillation |
18.0% |
| Product Used For Unknown Indication |
16.0% |
| Hypertension |
8.9% |
| Arrhythmia |
7.3% |
| Muscle Spasms |
2.2% |
| Fibromyalgia |
2.0% |
| Hormone Replacement Therapy |
2.0% |
| Cerebrovascular Accident |
1.8% |
| Diabetes Mellitus |
1.8% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii |
1.8% |
| Hypothyroidism |
1.8% |
| Anticoagulant Therapy |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Heart Rate Irregular |
1.6% |
| Hypokalaemia |
1.6% |
| Antibiotic Therapy |
1.3% |
| Unevaluable Event |
1.3% |
| Asthma |
1.1% |
|
| Skin Ulcer |
11.6% |
| Atrial Fibrillation |
10.1% |
| Ventricular Tachycardia |
8.7% |
| Alopecia |
5.8% |
| Bradyarrhythmia |
5.8% |
| Mixed Liver Injury |
5.8% |
| Sinus Bradycardia |
5.8% |
| Syncope |
5.8% |
| Vision Blurred |
5.8% |
| Treatment Noncompliance |
4.3% |
| Wrong Technique In Drug Usage Process |
4.3% |
| Arrhythmia |
2.9% |
| Asthenia |
2.9% |
| Cardiogenic Shock |
2.9% |
| Coma |
2.9% |
| Drowning |
2.9% |
| Medication Error |
2.9% |
| Palpitations |
2.9% |
| Respiratory Disorder |
2.9% |
| Sphincter Of Oddi Dysfunction |
2.9% |
|
| Concomitant |
| Atrial Fibrillation |
21.4% |
| Product Used For Unknown Indication |
19.8% |
| Drug Use For Unknown Indication |
12.1% |
| Hypertension |
8.3% |
| Pain |
5.8% |
| Arrhythmia |
3.7% |
| Cardiac Disorder |
3.4% |
| Multiple Myeloma |
3.4% |
| Rheumatoid Arthritis |
3.1% |
| Blood Cholesterol Increased |
2.9% |
| Osteoporosis |
2.8% |
| Nuclear Magnetic Resonance Imaging |
2.4% |
| Diabetes Mellitus |
1.6% |
| Prophylaxis |
1.4% |
| Cerebrovascular Accident Prophylaxis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Hypothyroidism |
1.4% |
| Anticoagulant Therapy |
1.3% |
| Asthma |
1.3% |
| Depression |
1.3% |
|
| Vomiting |
15.9% |
| Atrial Fibrillation |
8.5% |
| Weight Increased |
7.9% |
| Vision Blurred |
6.3% |
| Weight Decreased |
6.3% |
| Vertigo |
5.3% |
| Diarrhoea |
4.8% |
| Pneumonia |
4.8% |
| Drug Ineffective |
4.2% |
| Platelet Count Decreased |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Fatigue |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Ischaemic Stroke |
3.2% |
| Nausea |
3.2% |
| Pain |
3.2% |
| Pain In Extremity |
3.2% |
| Product Quality Issue |
3.2% |
| Rash |
3.2% |
| Sepsis |
3.2% |
|
| Interacting |
| Atrial Fibrillation |
40.0% |
| Chronic Myeloid Leukaemia |
20.0% |
| Fungal Skin Infection |
20.0% |
| Rheumatoid Arthritis |
20.0% |
|
| Drug Ineffective |
33.3% |
| Drug Interaction |
33.3% |
| Ventricular Arrhythmia |
33.3% |
|
